» Articles » PMID: 17879275

Time Trends of Physician Visits for Crohn's Disease and Ulcerative Colitis in the United States, 1960-2006

Overview
Specialty Gastroenterology
Date 2007 Sep 20
PMID 17879275
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of this study was to analyze physician visits associated with inflammatory bowel disease in the United States in order to shed light on the underlying disease time trends in the United States.

Methods: The National Diseases and Therapeutic Index of IMS America from 1960 until 2006 was used as the data source. Survey data had been obtained from a representative sample of U.S. physicians 4 times per year during a 48-hour period and extrapolated to a national level. All physician visits for Crohn's disease and ulcerative colitis were expressed as rates per 100,000 people living in the United States.

Results: Physician visits for Crohn's disease increased almost 5-fold between 1960-1964 and 1990-1994 and have leveled off since then. Except for a slight decrease between 1960-1964 and 1980-1984, physician visits for ulcerative colitis have remained largely unchanged, especially during the most recent 15 years. Similar trends were observed for both men and women.

Conclusions: U.S. time trends of physician visits are similar to other previously published time trends of inflammatory bowel disease. It appears that the overall incidence of inflammatory bowel disease has remained stable in the past 15 years.

Citing Articles

Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease.

Rubio M, Amo-Mensah K, Gray J, Nguyen V, Nakat S, Grider D World J Gastrointest Pathophysiol. 2020; 10(5):54-63.

PMID: 31911845 PMC: 6940564. DOI: 10.4291/wjgp.v10.i5.54.


Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014.

Ballou S, Hirsch W, Singh P, Rangan V, Nee J, Iturrino J Aliment Pharmacol Ther. 2018; 47(7):913-921.

PMID: 29411411 PMC: 5927595. DOI: 10.1111/apt.14551.


Position of the Canadian Association of Gastroenterology on subsequent entry biologics is challenged by biosimilar industry representatives.

Sebeszta M, Kudrin A Can J Gastroenterol Hepatol. 2014; 28(8):452-3.

PMID: 25229467 PMC: 4210237. DOI: 10.1155/2014/347382.


Chronic constipation: new diagnostic and treatment approaches.

Lacy B, Levenick J, Crowell M Therap Adv Gastroenterol. 2012; 5(4):233-47.

PMID: 22778789 PMC: 3388525. DOI: 10.1177/1756283X12443093.


Pros and cons of medical management of ulcerative colitis.

Navaneethan U, Shen B Clin Colon Rectal Surg. 2011; 23(4):227-38.

PMID: 22131893 PMC: 3134802. DOI: 10.1055/s-0030-1268249.